Alferon N Injection: IFSC began a U.S. Phase I/II trial of Alferon N as an adjuvant therapy given prior to surgical tumor resection in an undisclosed number of

Interferon Sciences Inc. (IFSC), New Brunswick, N.J. Product: Alferon N Injection Business: Cancer Therapeutic category: Immune modulation Target: Unknown Description: Injectable Interferon alfa-n3 I...